Drug LitigationSystematic Reviews Show Paroxetine Substantially Increases Risk of Birth Defects

November 12, 2011

Paroxetine, more commonly known by its trade names Paxil, Aropax, Seroxat, and Sereupin, is a commonly prescribed selective serotonin reuptake inhibitor (SSRI) aimed at treating depression.

 

Although effective at its primary purpose, paroxetine treatments have been shown in systematic reviews to substantially increase the risk of birth defects when taken during pregnancy. Specifically, on average paroxetine has been shown to increase the risk of pregnancy-related injuries, including a 1.5-fold increase in congenital birth defects and heart defects such as persistent pulmonary hypertension (PPHN).

 

If you or a loved one have given birth to a child who suffered from birth defects and who may have been exposed to paroxetine during his or her pregnancy, you should contact the dangerous drug attorneys at Nachawati Law Group. With years of experience handling these types of cases and successfully representing class action clients, we’re ready to give you search for justice the expert attention you need. Justice for you and your family may be just a phone call away. We’re ready to fight for you!

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy